EP3274478
HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.6.2015EP published:
23.9.2020EP application number:
15888046.8
EPO information:
European Patent Register
Max expiry date:
21.6.2035
Title:
HCV NS4A/MODIFIED NS3 POLYPEPTIDES AND USES THEREOF
Timeline
Today
22.6.2015EP application
23.9.2020EP Publication
Owner
Name:
Ortho-Clinical Diagnostics, Inc.Address:
1001 U.S. Route 202, Raritan, NJ 08869, US
Name:
Ortho Clinical Diagnostics, K.K.Address:
1-11-2 Osaki Shinagawa-ku, Tokyo 141-0032, JP
Name:
Grifols Worldwide Operations LimitedAddress:
Grange Castle Business Park Grange Castle Clondalkin, Dublin 22, IE
Inventor
Name:
CHIEN, David, Y.Address:
Alamo, CA 94507, US
Name:
COIT, Doris, GuenziAddress:
Petaluma, CA 94952, US
Name:
FUJIHARA, ToshiyaAddress:
Urayasu-shi Ot 279-0021, JP
Name:
GYENES, AlexanderAddress:
San Francisco, CA 94110, US
Name:
HALL, John, AndrewAddress:
Rohnert Park, CA 94928, US
Name:
MEDINA-SELBY, AngelicaAddress:
San Francisco, CA 94131, US
Name:
ZHENG, JianAddress:
Raritan, NJ 08869, US
Priority
Number:
201562139183 PDate:
27.3.2015Country:
US
Classification
Categories:
C12Q 1/70, G01N 33/53, G01N 33/567, G01N 33/00, C07H 21/04